This week the IMF supported making the renminbi a reserve currency, the deputy head of the CSRC was suspected of corruption, Dali Foods' IPO raised $1.5 billion and China clamped down on DVD imports
November 17, 2015
China Law News
New rules expand tax super-deductions to all R&D-related expenses including outsourcing fees and simplify guidelines with a negative list. Companies no longer need approval and can expect fewer negotiations with authorities
November 17, 2015Online apps including Weibo and WeChat have been regulated for copyright and the CSRC has abolished prepayments for IPOs and increased disclosure requirements for issuers and underwriters
November 12, 2015This week JD.com requested the SAIC to investigate Alibaba for pressuring vendors, internet companies like Baidu, Huawei and Sina were listed for data violations and R&D centers were allowed to seek drug approvals
November 10, 2015A new market access negative list will be tested in selected regions starting in December. It will be applied nationwide in 2018 along with one just for foreign investment as China further opens its gates
November 10, 2015Cloud computing service providers in China have to actively remove copyright-infringing content from their networks and put in place systems to prevent users from sharing such works. Rights owners welcome the development but data privacy concerns emerge
November 06, 2015More tax deductions are available for R&D expenses, technology transfers can get exempted from enterprise income tax and insurance companies no longer require CIRC approval to set up rep offices overseas
November 05, 2015The latest revisions increase corruption penalties, allow for subjective decisions and widen the information security net as China intensifies crackdown
November 04, 2015This week the FDA found Pfizer's plant in China falsified records and used old ingredients, a U.S. defense group report questioned IBM, Cisco and Microsoft's local partnerships and China's leading travel service companies combined
November 02, 2015This week the FDA found Pfizer's plant in China falsified records and used old ingredients, a U.S. defense group report questioned the local partnerships of IBM, Cisco and Microsoft and China's leading travel service companies combined
November 02, 2015
